GlassScriptPhysician profile
Kevin M Freeman
NPI 1932328457
$3,007.06
in general payments reported to CMS, 2019-2025
11 companies · $194 in 2025
The $194 reported for 2025 was more than what 75% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $50.02 · 2021: $81.64 · 2022: $13.44 · 2023: $2,454 · 2024: $104 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598 · Travel and Lodging: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.50 |
| Travel and Lodging | $1,154.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonendo INC | $2,033.00 | 2023-2024 | Gentlewave Console, Gentlewave G4 Console |
| Dentsply Sirona INC | $642.36 | 2019-2025 | Suresmile, Implant Dentistry, Cerec |
| Dental Health Products, INC. | $118.61 | 2025 | |
| Philips North America LLC | $52.24 | 2019 | |
| Patterson Companies, INC. | $38.00 | 2023 | |
| Nusmile, LTD. | $27.48 | 2025 | Ab - Zarc System |
| Align Technology, INC. | $24.89 | 2019 | |
| Solventum Corporation | $23.61 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| 3m Company | $21.43 | 2023 | Scotchbond Universal Plus, 3m Relyx |
| Ultradent Products INC | $13.99 | 2019 | |
| Ivoclar Vivadent, INC. | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.